Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novartis -- Ignore unavailable to you. Want to Upgrade?

To: Starlight who wrote (187)	4/8/1998 12:59:00 PM
From: Starlight	Read Replies (1) \| Respond to of 296

News about Novartis in the San Diego paper today. A new genetics research center will open here this year financed by a $250 million grant from Novartis. The facility will study how individual genes contribute to diseases and develop treatments for them. The facility will be called Novartis Institute for Functional Genomics, and will employ about 100 people, including 20 principal scientists. The $250 million grant should finance the lab's entire operation for a decade. The company will have first rights to products coming from the new lab, but would pay a fee or royalty for use of discoveries.